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This study quantitatively evaluated the change in myo-
cardial blood flow resulting from medical revasculari-
zation in patients with acute anterior myocardial in-
farction. Changes in great cardiac veinflow weremeasured
using a thermodilution technique in 13 patients with
acute infarction; 3 received intracoronary streptokinase
and to percutaneous transluminal angioplasty. Average
great cardiac vein flow during left anterior descending
coronary artery occlusion was 62 ± 6 ml/min and in-
creased to 70 ± 7 ml/min (p = 0.039) after arterial
recanalization. There was significant individual varia-
bility in the great cardiac vein flow increments that was
highly predictive of functional recovery as expressed by
the change in ejection fraction at 7 to 10 days (r =0.93,
p = 0.0008). Incremental great cardiac vein flow was
inversely correlated with the degree of residual stenosis
and the duration of ischemia (r = 0.88, p = 0.0007).
Medical revascularization in patients with acute myocardial
infarction by means of intravenous or intracoronary throm-
bolytic therapy or by percutaneous transluminal coronary
angioplasty is finding wide application. The rationale for
these efforts is based on the assumption that restoration of
myocardial blood flow will restore regional myocardial
function , thereby preventing cardiac failure and improving
prognosis . However. changes in coronary flow during acute
medical revascularization have not been quantitatively eval-
uated. Angiographic documentation of arterial patency after
an intervention has been used to define successful medical
revascularization, but despite restoration of arterial patency ,
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Patients with residual stenosis s50% had a significantly
larger increase in great cardiac vein flow(14 ± 5 ml/min)
than did those with residual stenosis> 50% (0 ± 2 mIlmin,
p = 0.026). Neither preinterventional left ventricular
ejection fraction, hemodynamics nor age predicted in-
cremental great cardiac vein flow.
Therefore, quantitative measurements of great car-
diac vein flow during medical revascularization in pa-
tients with an acute anterior myocardial infarction dem-
onstrate variable reflow that is physiologicalIy significant.
A high grade residual stenosis and prolonged period of
ischemia limit large increases in flow and prevent func-
tional recovery. This study emphasizes the fact that re-
canalization in itself cannot be used as an indicator of
the success of interventions designed to produce myo-
cardial reperfusion.
(1 Am CoLl CardioI1987;10:284-9)
thallium scintigraphy and radionuclide and angiographic
ventriculography often show postreperfusion defects and
wall motion abnormalities, raising the possibility that res-
toration of flow may have been too late or inadequate (1-6) .
Quantitative documentation of changes in myocardial blood
flow is essential to evaluate the efficacy of acute reperfu sion
and its relation to myocardial salvage. The purpose of this
study was to quantitatively assess the degree of coronary
reflow resulting from medical revasculari zation in patients
with acute anterior myocardial infarction . Coronary blood
flow was assessed by measuring the change in great cardiac
vein flow using a thermodilution technique before and after
reperfusion . These flow alterations were then correlated with
chan ges in ventricular function.
Methods
Patient selection. Patients between the ages of 20 and
80 years, presenting to the University of Michigan Hospitals
between November 10, 1983 and August 15, 1985 with an
0735-109 7/87/$3 .50
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acute anterior myocardial infarction, were eligible for in-
clusion. Acute anterior infarction was defined as I) presen-
tation within 12 hours of the onset of chest pain, with
electrocardiographic (ECG) ST segment elevation 2':2 mm
in standard precordial leads V I or V2, 2) the presence of a
proximal left anterior descending coronary artery occlusion
by angiography, and 3) evidence of anterior wall dysfunc-
tion by ventriculography. Written informed consent for
emergent cardiac catheterization and myocardial reperfusion
was obtained in accordance with hospital policy.
Patients were excluded if they had a previous anterior
myocardial infarction as evidenced by Q waves in anterior
leads V I to V3 on prior ECGs or had previous enzymatic
documentation of infarction with transient anterior ECG
ischemic changes. Patients were excluded from thrombol-
ytic therapy if they had undergone major surgery or trauma
within 2 months, had a history of stroke within 3 months,
were actively bleeding or had a presumed streptokinase al-
lergy. Eighteen patients met these study criteria,
Protocol. Coronary sinus multithermistor thermodilu-
tion pacing catheters were inserted percutaneously or by cut
down antecubital venotomy from the left arm (7). The distal
thermistor was positioned with fluoroscopic guidance into
the great cardiac vein and oriented to measure anterior wall
venous drainage. Contrast medium, I ml, was injected into
the catheter and recorded on cine film to be used as a ref-
erence for catheter position. Patients who had any detectable
catheter movement from this reference position were ex-
cluded from subsequent analysis. For each venous flow mea-
surement normal saline was injected into the catheter at a
rate of I mils for 20 to 30 seconds until stable thermistor
output was recorded. Coronary venous flows were measured
during total left anterior descending coronary artery occlu-
sion and up to 30 minutes after revascularization as evi-
denced by angiographic coronary artery reflow. All patients
received either intracoronary streptokinase (250,000 u over
30 minutes) or angioplasty. Interventional therapy was not
delayed by coronary sinus catheter placement or great car-
diac vein flow determinations. Right anterior oblique ven-
triculograms were recorded during injection of 30 to 40 ml
of radiocontrast into an 8F pigtail catheter placed in the left
ventricle after revascularization. Coronary venous flows were
intermittently measured for at least 30 minutes after reflow
until the end of the procedure when all catheters were re-
moved before the patient left the catheterization laboratory.
All patients were transferred to the coronary intensive care
unit for postinfarction management. They received full dose
intravenous heparin anticoagulation when fibrinogen levels
were> 100 pJl OOcc. In addition, after angioplasty, patients
were given aspirin, 325 mg every 8 hours, dipyridamole,
75 mg every 8 hours, and diltiazern, 60 mg every 6 hours,
Subjects underwent repeat coronary and left ventricular an-
giographyapproximately 10 days after the acute intervention
to assess arterial patency and left ventricular function.
Calculations. Anterior wall venous flow was calculated
from the following formulas:
Ilt'
GCV flow = (IltGCy-1) (INF FLOW) (K),
where Ae = temperature difference between blood and
infusate, AtGC V = change in great cardiac vein thermistor
temperature during infusion, INF FLOW = flow rate of
infusate and K = constant for relative specific heats of blood
and injectate = I. I for saline solution.
Multiple (two to three) flow measurements were made
before and after angiographic refiow. Reported results rep-
resent averages of these repeated determinations. In patients
undergoing angioplasty, great cardiac vein flow during left
anterior descending coronary artery occlusion was verified
during inflation of the angioplasty balloon. Anterior wall
vascular resistance was calculated as mean arterial pres-
sure/great cardiac vein flow.
Ventriculograms at the time of acute intervention and at
repeat catheterization were analyzed by two observers to
calculate ejection fractions. An area/length single plane
method was used as follows:
Volume (em) = RCI x 8/3 x A/L + RC1,
where A = area of the ventricle at diastole or systole, L
= length of longest chord, RC I = regression coefficient
No. I = 0.81 for right anterior oblique projection and RC 2
= regression coefficient No. 2 = 1.9 for right anterior
oblique projection.
Residual coronary stenosis remaining after the interven-
tion was independently determined using caliper measure-
ments estimated by two observers who were unaware of
patient data. The average of these determinations was used
for further data analysis. The mean percent stenosis was
compared with the percent diameter coronary stenosis es-
timated by an automated technique in 7 of the 13 patients
(8) .
Data analyses. All group data are expressed as mean
values ± SEM. Baseline and postintervention coronary ve-
nous flows were compared with a paired t test. Standard
linear regression analysis was used to determine the cor-
relation between variables.
Results
Patient characteristics. Of the 18 patients who met the
study criteria, 2 streptokinase-treated patients were excluded
because arterial reflow occurred before baseline coronary
venous flow determinations were made and an additional 2
patients were excluded because of unstable coronary sinus
catheter position. Angioplasty failed to revascularize the
occluded artery in one patient and his data were omitted
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Figure 2. Linear regression relating incremental great cardiac vein
(GCY) flow to percent residual coronary stenosis. Note that the
relation appears to be linear over the full range of residual stenosis.
differences between repeated final flow measurements were
< 4 rnl/rnin.
Average hemodynamic changes are shown in Table J.
Mean heart rate and mean arterial blood pressure were un-
changed. Individual increments in great cardiac vein fl ow
ranged from -7 to 28 ml/rnin. Calculated anterior wall
resistance decreased 16 ± 7 dynes-s-cm " (p = 0.036).
Residual stenosis ranged fro m JO to 90%. Interobserver
variability was small, and the correlation coefficient be-
tween observers was 0.89. The percent diameter coronary
stenosis estimated by the automated technique correlated
well with the mean value determined by the observors (r
= 0 .8 5 , largest difference = 16%) .
from analysis. One angioplasty-treated patient had sponta-
neous resolution of pain, ventricular arrhythmias and partial
resolution of ST segment changes 15 minutes before cath-
eterization. Initial angiography demonstrated left anterior
descending coronary artery patency. Occlusion flows in this
patient were obtained during angioplasty. Therefore, the
study group consisted of 13 patients, 11 men and 2 women.
The average age was 55 years (range 34 to 77). The time
from onset of chest pain to arterial reflow was between 2.25
and 8.75 hours (mean 5.92).
Ten patients underwent coronary revascularization with
angioplasty and three with streptokinase. Eight patients had
a repeat catheterization between 8 and II days (mean 10)
after acute intervention. All were men between the ages of
36 and 72 years (mean 52). The time from symptom onset
to arterial reflow was 2.75 to 8.25 hours (mean 5.9). The
eight patients with repeat catheterization included two treated
with streptokinase and six with angioplasty. No patients had
postinfarction angina.
Great cardiac vein flow (Fig. I to 3). Average great
cardiac vein flow during left anterior descending coronary
artery occlusion was 62 ± 6 ml/min and increased to 70
± 7 ml/min (p = 0.039) after angiographic demonstration
of arterial recanalization. Individual fl ow changes are shown
in Figure I. In some patients, repeated measurements of
flow showed some variability. However, significant " zero"
drift (>3 ml/min) occurred only in patients with unstable
catheter position. After recanalization, four patients with a
large increase in great cardiac vein flow after angioplasty
appeared to demonstrate reactive hyperemia after balloon
inflation. Therefore, final reflow determinations were made
at least 30 minutes after balloon inflation. The largest hy-
peremic great cardiac vein flow in these patients was 1.3
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Figure I. Absolute changes in great cardiac vein flow before and
after left anterior descending coronary artery recanalization. Ten
patients underwent revascularization with angioplasty and three
with intracoronary streptokinase.
Figure 3. Linear regression relating incremental great cardiac vein
(GCY) flow to the duration of ischemia in hours. The time range
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Table 1. Effect of Coronary Reperfusion on Hemodynamics in 20
13 Patients
Preintervention Postintervention 16 0
"-Heart rate 96 ± 4 93 ± 5 ~ 12
(beats/min) "".:: 0 0Q)
Arterial pressure 88 ± 3 89 ± 3 o
...
(mean) (mm Hg) Q)0..
Great cardiac vein flow 62 ± 6 70 ± 7* ,5 0
(mllmin) Q)blI 0Anterior wall resistance 131 ± I7 liS ± 14t .::
'"(dyne-s-cm - 5) ..:: o iu I
I y ~ -,598 + .568X*p = 0.039: t = 0.036. r ;:;: .93
-4 0 P < .001
Incremental great cardiac vein flow was inversely and
independently correlated with residual stenosis and the du-
ration of ischemia in hours: Predicted great cardiac vein
flow increment = 40,31 - 0,29 (% residual stenosis) -
2,77 duration (r = 0.88, p = 0.007). Preinterventional
ejection fraction, heart rate, blood pressure and age did not
contribute significantly to the predictive model. Univariate
correlations of incremental great cardiac vein flow revealed
that residual stenosis was a more significant predictor than
the duration of ischemia (r = 0,77, P = 0,002 versus r =
0.65, P = 0,0155) (Fig, 2 and 3),
Patients with a residual stenosis :::;50% had a significantly
larger increase in great cardiac vein flow than those with a
residual stenosis >50% (14 ± 7 mllmin versus 0 ± 2 [p
= 0,026]). Only three patients received intracoronary strep-
tokinase, but none experienced an increase in great cardiac
vein flow, and all were left with a high grade residual ste-
nosis (Fig, 1),
Ejection fraction. Left ventricular ejection fraction dur-
ing acute intervention ranged from 34 to 56% (mean 44).
In patients undergoing repeat catheterization, initial ejection
fraction increased from 44 ± 3 to 48 ± 3% at 10 days (p
= NS), In these eight cases, great cardiac vein flow in-
creased from 56 ± 8 to 64 ± 9 mllmin (range - 6 to 26)
(p = NS). These acute changes in great cardiac vein flow
during revascularization were highly correlated with changes
in ejection fraction at 10 days (r = 0.93, P = 0.0008) (Fig.
4), All patients demonstrated arterial patency at repeat cath-
eterization.
Loading conditions varied between the initial and repeat
catheterizations but there was no correlation between the
change in ejection fraction and the alteration in hemody-
namics. Initial heart rate (83 ± 6 versus 77 ± 4 beats/min),
mean systemic blood pressure (93 ± 7 versus 79 ± 5 mm
Hg, p = NS) and left ventricular end-diastolic pressure (26
± 3 versus 17 ± 3 mm Hg, p = NS) tended to be higher
during the acute intervention than at the repeat catheteriza-
tion in this subgroup, However, the addition of all three
hemodynamic variables did not significantly improve the
-8 +--,----+----,---,--,.--,----,-----,
-10 -5 0 5 10 15 20 25 30
Change in GCV Flow (ml/min)
Figure 4. Linearregression relatingthechangeinejectionfraction
(EF) at 10 days after intervention to the acute increment in great
cardiac vein (GCY) flow during arterial recanalization.
correlation between the change in ejection fraction and in-
cremental great cardiac vein flow (r = 0,93 versus 0,97),
Discussion
Variable reftow. This study demonstrates that coronary
revascularization in patients with an acute anterior myo-
cardial infarction produces variable reflow. Furthermore,
functional recovery at 7 to 10 days can be predicted by the
acute change in great cardiac vein flow. Similar variability
in reflow after prolonged (>90 minutes) ischemia has also
been demonstrated in animal models (9). In the dog, at least
a portion of the variability appears secondary to ' 'no reflow"
zones within the postischemic myocardium (9), Perfusion
to these areas is impaired by microvascular deterioration
and capillary plugging with blood components such as leu-
kocytes (10, II). Thus, reperfusion after prolonged ischemia
in animal models may not restore flow to preischemic levels.
The average increment in great cardiac vein flow in the
present study was only 8 ml/rnin. Although preischemic
basal flows could not have been measured in these patients,
previous determinations of great cardiac vein flow using the
same thermodilution technique have demonstrated a 20 to
30 milmin decrease in flow during transient proximal left
anterior descending coronary artery occlusion (7), If reper-
fusion was maximally successful, one would therefore pre-
dict a 20 to 30 ml/min increment in coronary blood flow.
Reperfusion in humans after prolonged ischemia appears to
resemble the animal models in failing to restore flow to
preischemic levels. Because the average duration of isch-
emia in this study was 5.9 hours, "no reflow" zones are
likely to have been present reducing or, in some cases,
abolishing expected flow increments. Similar conclusions
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can be drawn from the finding of persistent thallium per-
fusion defects after thrombolytic therapy (6). In four pa-
tients, great cardiac vein flow decreased after recanalization,
suggesting that some reperfusion injury may have occurred.
Determinants of reflow. The results of this study in-
dicate that both residual coronary stenosis and duration of
ischemia are major determinants of incremental great car-
diac vein flow at the time of reperfusion in patients with
acute anterior myocardial infarction. High grade residual
stenosis was the most important predictor of reflow (p =
0.002, Fig. 2). Patients with stenosis >50% after interven-
tion had no significant increments in great cardiac vein flow;
all increases were <6 mllmin (average ± 2). In contrast,
patients with residual stenosis -::::50% had a larger change
in great cardiac vein flow (average + 14 mllmin, range -4
to +28).
Prolonged ischemia also appeared to limit reflow (Fig.
3). Regression analysis suggests that significant increases
in great cardiac vein flow were unlikely to be achieved after
6 to 7 hours. A wider time span, including more patients
with a shorter period of ischemia, might have revealed an
even stronger relation. In addition, the true duration of coro-
nary occlusion is difficult to clinically define. Intermittent
or progressive occlusion in some patients may have resulted
in inaccurate estimations of the ischemic insult.
Comparison with previous studies. These results are
consistent with observations of other investigators. Using a
technique of quantitative coronary arteriography, Sheehan
et al. (12) showed a similar inverse correlation between
regional functional recovery and the degree of residual ste-
nosis. However, only severe stenoses <0.4 mm in minimal
diameter failed to show significant improvement in their
study. In the present study, less severe stenoses also ap-
peared to limit reflow. Diffuse atherosclerotic or thrombotic
narrowing of the involved artery could have led to an an-
giographic underestimation of critical disease. Alterna-
tively, the disturbed endothelial topography after angio-
plasty may produce unusual turbulence further limiting flow.
Additional variables are likely to modify the ischemic
insult and the potential for full restoration of flow. The
results of the National Heart, Lung, and Blood Institute
Cooperative Study of Animal Models (13) demonstrated that
anatomic risk region, collateral blood flow to the central
ischemic zone and the pressure-rate product during ischemia
accounted for 80 to 90% of the variability in infarct sizes
in dogs undergoing a 3 hour coronary occlusion reperfusion
protocol. In the present study, no good correlate was avail-
able for any of these variables. All patients had proximal
left anterior descending coronary artery occlusion, but there
was almost certain variability in anatomic risk mass. No
index was available for estimating collateral flow. Myo-
cardium receiving large collateral flow essentially replacing
normal anterograde flow and reducing the region at risk of
infarction would have contributed equally to great cardiac
vein flow before and after arterial recanalization. Even the
rate and pressure recorded at the time of acute intervention
are unlikely to be representative of these variables through-
out the ischemic period. These factors undoubtedly con-
tributed to the variability in incremental great cardiac vein
flow in the present study, but there is no way of quantitating
their significance.
Limitations of the technique. Thermodilution mea-
surements of coronary blood flow have been previously
validated in humans and widely used in clinical studies
(14-18). However, the technique has significant limitations.
Small changes in the position of the thermistor relative to
coronary sinus branches can produce large technical artifacts
in flow (19). Attempts to measure coronary sinus as opposed
to great cardiac vein flow can be additionally complicated
by coronary sinus reflux (20). Thus, in this protocol only
great cardiac vein flow was measured and extreme care was
taken to stabilize and document catheter position.
The specificity of great cardiac vein flow for anterior
wall drainage is imperfect. Total occlusion of the proximal
left anterior descending coronary artery is associated with
only an average 33% decrease in great cardiac vein flow
(7). During occlusion of this artery, the remaining great
cardiac vein flow presumably represents collateral flow to
the anterior wall as well as drainage from other coronary
artery territory. In addition, the absolute fall in great cardiac
vein flow during transient proximal coronary occlusion is
only 20 to 30 mllmm. Thus, flow and changes in left anterior
descending coronary artery flow are not directly measured
by changes in great cardiac vein flow but, instead, serve as
an index of this flow.
The changes in great cardiac vein flow during recanal-
ization did not appear to be confounded by hemodynamic
fluctuations. Repeated measurements of great cardiac vein
flow were reproducible over the relatively short observation
period. Postischemic reactive hyperemia was seen in only
four patients, all of whom had a large great cardiac vein
flow increment. Even in these patients, the degree of reactive
hyperemia was small, the largest being 1.3 times flow 30
minutes after recanalization.
Implications. Our results show that restoration of flow
with medical revascularization is essential for improvement
in myocardial wall motion. The acute changes in great car-
diac vein flow after reperfusion predicted the subsequent
changes in ejection fraction. Because the increments in great
cardiac vein flow are critically dependent on both the du-
ration of ischemia and the degree of residual stenosis, further
effort should be directed toward minimizing the duration of
ischemia by early application of intravenous thrombolytic
therapy and relief of any significant residual stenosis by
angioplasty or coronary artery bypass grafting. Recanali-
zation in itself cannot be used as an indicator of the success
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of myocardial reperfusion. Reperfusion after prolonged pe-
riods of ischemia or through vessels with a high grade re-
sidual stenosis are unlikely to result in improved myocardial
function, one of the major goals of acute medical revas-
cularization.
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